News Releases

Click here to access press releases from Astellas Pharma Inc. located in Tokyo, Japan.

Get News Alerts by Email

Jan 23, 2018

Astellas Completes Acquisition of Mitobridge, Inc.
Jan 22, 2018

Astellas and Vical Announce Top-Line Results for Phase 3 Trial of Cytomegalovirus Vaccine ASP0113 in Hematopoietic Stem Cell Transplant Recipients
- Photos 1
Jan 8, 2018

Astellas Announces Leadership Changes in Canada and U.S.
- Photos 4
Dec 20, 2017

Astellas to Present at J.P. Morgan Healthcare Conference
Dec 13, 2017

Astellas Appoints Anthony Fiordaliso to Vice President, Americas Finance
- Photos 2
Dec 11, 2017

Astellas Announces First Clinical Data from Phase I Study of Gilteritinib in Combination with Intensive Chemotherapy in Patients Newly Diagnosed with Acute Myeloid Leukemia

- Gilteritinib combined with intensive chemotherapy was well-tolerated in newly diagnosed AML patients -
Dec 4, 2017

Astellas Appoints João Carlos de Britto as General Manager of Astellas Farma Brasil
- Photos 1
Nov 30, 2017

Astellas Acquires Mitobridge Under Existing Collaboration

- Accelerating the Discovery and Development of Novel Drugs that Target Mitochondrial Functions -
Nov 28, 2017

Astellas to Present New Data Exploring Gilteritinib in Newly Diagnosed Acute Myeloid Leukemia (AML) Patients at the 2017 American Society of Hematology Annual Meeting (ASH)

- A breadth of abstracts highlighting the acute myeloid leukemia treatment landscape, healthcare resource use and cost of care to be presented during oral and poster sessions -
Nov 16, 2017

Nearly 3,000 Women Across America Reveal Surprising Lengths and Locations They've Had to Go to Answer Nature's Urgent Call

Show per page